Twist Biosciences (TWST) Analysis

Innovation and Market Leadership:
Twist Biosciences TWST, a leader in synthetic DNA products, is set for substantial growth with its new Express Genes service, offering NGS-verified genes in just five to seven business days. This innovation is expected to strengthen Twist's market position and dominance.

Growth Forecast and Market Expansion:
The company forecasts a CAGR of over 28% through 2025, backed by a customer base of over 3,300 across various industries. Targeting multiple large addressable markets, Twist aims to sustain revenue growth for the foreseeable future.

Investment Outlook:

Bullish Outlook: We are bullish on TWST above the $41.00-$42.00 range.
Upside Potential: With an upside target set at $76.00-$78.00, investors should consider Twist's innovative service offerings and robust growth projections as key drivers for potential stock appreciation.

📊🧬 Monitor Twist Biosciences for promising investment opportunities! #TWST #SyntheticDNA 📈🔍